Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Simulations Plus, Inc. provides software and consulting services for drug discovery, development, and regulatory approval. Its core offerings include modeling and simulation tools like GastroPlus and ADMET Predictor, supporting pharmaceutical, biotech, and academic clients worldwide. The company enhances R&D efficiency, reduces costs, and accelerates time-to-market through innovative science-based solutions across the drug development continuum. It operates with a focus on scientific expertise, proprietary technology, and global customer relationships.
This description was generated via AI from an annual report. Updated about 1 year ago.